Cannabis
Doug Kass: Don't Believe All The Hype!
There are much broader implications beyond my unprofitable venture into cannabis stocks.
3 High-Yield Dividend Stocks With Cannabis Exposure
These names provide exposure to the cannabis industry, but also pay hefty dividends to shareholders.
Thursday's Rally Was Swell, but Powell Could Reverse That Momentum Quickly
It would be foolish to ignore the Fed chairman, who could sneeze and turn everyone bearish.
Big Tech Produces a Mixed Earnings Bag, but This Cannabis ETF Finally Perks Up
Meanwhile, the market indexes remain on cruise control as traders await Jerome Powell's utterances at Jackson Hole.
Doug Kass: 10 Reasons Why I Plan to Substantially Increase My Cannabis Holdings
It seems to me that federal legislation is inevitable.
A Cannabis ETF and a Micro-Cap Stock That Have Grabbed My Attention
The ETF is showing signs of perking up and the micro-cap is a maker of electric outboard motors.
Catch These 2 Cannabis 'Back Door' Plays on the Rebound
The risk/reward profiles of AGFY and MAP are enticing.
5 Cannabis Stock Favorites as the Battered Sector Battles Back
Tech stocks didn't disappear after the dot-com bubble; the cream of the crop came back healthier than ever. And so will the best-run cannabis stocks.
Is Tilray Going Up in Smoke?
Shares of the cannabis company have provided a rude awakening for buy-and-hold investors.
Chipmakers Show Some Life, but Don't Rush Into Building Positions in Them
The same can be said of cannabis stocks as fresh talk of federal legislation to legalize marijuana likely is just that… talk.
Is a Stealth Bull Market Developing in These Long-Suffering Sectors?
I have my eye on relative strength in groups that have lagged for a very long time.
As the Market Struggles to Bounce Back, Here's My Game Plan
Many stocks are very oversold, and sentiment is about as bad as it gets.
A New Pot ETF Just Lit Up, So Let's Get Deep Into the WEEDs
Here we'll hash out the differences among cannabis players and see high how Roundhill Investment's The Cannabis ETF can go.
Mosaic's Chart Pattern Suggests Its Share Price Could Grow Even Bigger
Pressure on fertilizer supplies due to sanctions against Russia because of the war in Ukraine makes the potash producer a star performer in a down market.
I Wouldn't Go 'All In' on Tilray, But Here's How I'd Trade It
Tilray is okay in my book for speculation.
Watching for an Upside Move in Cannabis Names
There should be some better trading action and setups as things pull back.
If You Don't Want to Be Slaughtered on the Trading Battlefield, Develop a Plan
It isn't brave to trade without a game plan; it's foolhardy and can result in big losses.
These Oil, Cannabis and Bitcoin Stocks Are on My Radar
Small-caps and growth names are relatively weak.
Gauging If We're Seeing a Bear Market Bounce or Start of a V-Shaped Recovery
Let's check out the 21-day exponential moving averages of SPY and QQQ for clues and also look at three stocks for trading ideas.
Here's My Acid Test on 2 Recently Launched Psychedelics ETFs
While performance hasn't been mind blowing so far, psychedelics are where cannabis was a decade or so ago.
Keeping an Eye on 2 Cannabis Stocks Until Market Conditions Improve
I'm looking at a possible inverse head and shoulders forming on many cannabis charts.
This Isn't a Market That Can Be Easily Trusted
Yet there's good relative strength in biotech, growth, cannabis, small-caps, and other sectors that have been the biggest laggards.
To Deal With Volatility, Consider These 3 Options on the Risk Spectrum
They range from doing nothing to jumping into the day-trading fray.
Tilray Isn't Going to Get That High
TLRY posted promising earnings, but don't expect it smoke past its current levels for long.
I Wouldn't Jump on the Tilray Bandwagon, But Here's What I Would Do
You think the Tilray brand name is worth $2.8B? Market cap is barely above $3B. Does give me pause.
I'm Treading Carefully Entering 2022 as Many Momentum Stocks Remain Bearish
Cannabis is about the only space where I'm long, and that isn't for technical reasons.
2021 Year in Review: A Very Good Market for Mega-Cap Stocks... But Not Much Else
The broader market had a very tough go of it in 2021, but you wouldn't know it unless you do some digging. From Reddit and Diamond Hands to SPACs and a stealth bear market, it's been a wild ride.
Precious Metals and Cannabis Could Surprise to the Upside in 2022
And there are a few ETFs and a silver miner that could provide the vehicles to play this hunch.
With BAD and VICE ETFs, the Devil Is in the Details
Will these exchange-traded funds pay off or send your portfolio up in a 'PUF'?
We Have Thin and Random Trading But an Upbeat Bias
We're in good shape for a continuation of the upside action next week.